Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lidocaine hydrochloride + bupivacaine hydrochloride + povidone-iodine + isopropyl alcohol
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Injection, Topical
01
Overview
This product is a **procedural anesthesia kit** that combines the local anesthetics **lidocaine hydrochloride** and **bupivacaine hydrochloride** with the skin antiseptics **povidone-iodine** and **isopropyl alcohol**. The anesthetic components are small-molecule amide local anesthetics that produce local or regional anesthesia primarily by **reversibly blocking voltage-gated sodium channels** in peripheral nerves, thereby preventing initiation and propagation of nerve impulses. The povidone-iodine and isopropyl alcohol components are included for **skin preparation and antisepsis** before injection or block placement rather than for direct analgesic effect. Based on the provided context, this exact four-component product is represented by the kit name **Point Of Care LM 2.5** and is used in anesthesia-related procedures.
- Brand names
- Point Of Care LM 2.5
- Other names
- lidocaine hydrochloride + bupivacaine hydrochloride + povidone-iodine + isopropyl alcohol
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on lidocaine hydrochloride + bupivacaine hydrochloride + povidone-iodine + isopropyl alcohol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lidocaine hydrochloride + bupivacaine hydrochloride + povidone-iodine + isopropyl alcohol.